Navigation Links
KENSEY NASH Receives FDA 510(k) Clearance for ECM Product, Meso BioMatrix Surgical Mesh
Date:5/26/2010

EXTON, Pa., May 26 /PRNewswire-FirstCall/ -- Kensey Nash Corporation (Nasdaq: KNSY), a leading medical technology company that provides innovative resorbable biomaterial technology for a wide range of medical procedures, today announced that it has received 510(k) clearance from the U.S. Food and Drug Administration for its second extracellular matrix (ECM) product, the Meso BioMatrix™ product. The clearance allows for the use of Meso BioMatrix in general surgery for the reinforcement and repair of soft tissue, including hernia repair, plastic and reconstructive surgery, and urologic, gynecologic and gastroenterologic applications.

The Meso BioMatrix product is a porcine-based mesothelium (Meso) extracellular matrix designed to reinforce soft tissues where weakness exists in patients requiring soft tissue repair.   Medeor™ Matrix, the Company's previously cleared dermal matrix product, and the Meso BioMatrix product are manufactured using Kensey Nash's proprietary Optrix™ process, which gently disinfects tissues, inactivates viruses and removes cells while preserving extracellular matrix components.  Kensey Nash is currently evaluating partnering opportunities for the Meso BioMatrix products in the urogynecology, wound care, orthopaedic and other markets.  

"This regulatory clearance represents another important milestone in our plans to build upon Kensey Nash's leadership position as a developer of innovative regenerative medicine products," commented Doug Evans, Chief Operating Officer of Kensey Nash. "Meso BioMatrix and Medeor Matrix represent two distinct pro
'/>"/>

SOURCE Kensey Nash Corporation
Copyright©2010 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related medicine technology :

1. Kensey Nash to Present at the Ninth Annual JMP Securities Research Conference
2. Kensey Nash Corporation Announces the Addition of Donald Morel, Jr., Ph.D. to Its Board of Directors
3. Kensey Nash To Participate in the Sidoti Fourteenth Annual New York Emerging Growth Institutional Investor Forum
4. Kensey Nash to Present at the Canaccord Adams Musculoskeletal Conference
5. Kensey Nash Announces $30 Million Share Buyback
6. Kensey Nash Reports Second Quarter Fiscal Year 2010 Financial Results
7. Kensey Nash Receives FDA 510(k) Clearance for Porcine Dermis Biologic Product
8. Kensey Nash Corporation Announces Its First Quarter Fiscal Year 2010 Earnings Release Date and Teleconference
9. Kensey Nash Announces Presentations on its Cartilage Repair Device at the International Cartilage Repair Society Meeting
10. Kensey Nash Announces IDE Submission for Cartilage Repair Device
11. HealthWarehouse.com Receives VIPPS Accreditation From The National Association of Boards of Pharmacy
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/20/2013)... May 20, 2013  Hill-Rom Holdings, Inc. (NYSE: ... management presentation at the 38 th Annual Deutsche ... on May 30, 2013, at 1:30 p.m. EDT. ... You are invited to listen to the live discussion ... access it directly at http://www.media-server.com/m/p/f7bj3q84 . A recorded ...
(Date:5/20/2013)...  TRACE International today released its Global Enforcement ... against individuals and government or business entities for bribery ... 2012 is the third in an annual series ... "Although the number of outbound enforcement actions fell ... priority," said Alexandra Wrage , TRACE ...
(Date:5/20/2013)... 20, 2013  Echo Pharma Acquisition Limited ("Royalty Pharma") ... Takeover Rules (the "Announcement"), a firm intention to increase ... ELN ) to $12.50 per share in cash.  The ... conditional on due diligence.  The $1.00 per share net ... the right to waive down the Acceptance Threshold for ...
Breaking Medicine Technology:TRACE Releases 2012 Global Enforcement Report 2TRACE Releases 2012 Global Enforcement Report 3Royalty Pharma Increases Offer for Elan to $12.50 Per Share in All Cash 2Royalty Pharma Increases Offer for Elan to $12.50 Per Share in All Cash 3Royalty Pharma Increases Offer for Elan to $12.50 Per Share in All Cash 4Royalty Pharma Increases Offer for Elan to $12.50 Per Share in All Cash 5Royalty Pharma Increases Offer for Elan to $12.50 Per Share in All Cash 6Royalty Pharma Increases Offer for Elan to $12.50 Per Share in All Cash 7Royalty Pharma Increases Offer for Elan to $12.50 Per Share in All Cash 8Royalty Pharma Increases Offer for Elan to $12.50 Per Share in All Cash 9Royalty Pharma Increases Offer for Elan to $12.50 Per Share in All Cash 10Royalty Pharma Increases Offer for Elan to $12.50 Per Share in All Cash 11
...  theVisualMD, www.thevisualmd.com , the world,s leading health visualization resource ... Visual Rules of Wellness. Quest Diagnostics (NYSE: DGX ... services, is the official sponsor of the initiative,s first rule ... of Wellness aim to bring readers a new understanding of ...
... 3, 2012   GP Strategies Corporation (NYSE: ... of sales and technical training, e-Learning solutions, management consulting ... L.P. ("Sagard Capital") has agreed to purchase 350,000 shares ... The closing of the transaction is subject to customary ...
Cached Medicine Technology:theVisualMD Launches a Revolutionary New Visual Path to Wellness 2theVisualMD Launches a Revolutionary New Visual Path to Wellness 3theVisualMD Launches a Revolutionary New Visual Path to Wellness 4Sagard Capital Increases Ownership in GP Strategies by 350,000 Shares in a Private Transaction with Bedford Oak Partners, L.P. 2Sagard Capital Increases Ownership in GP Strategies by 350,000 Shares in a Private Transaction with Bedford Oak Partners, L.P. 3
(Date:5/20/2013)... In celebration of National Women’s Health Week and ... The Feinstein Institute for Medical Research and ... in Science and Medicine (AWSM) , hosted its second ... business and community leaders from the region attended the ... science. , “Women face unique barriers to success ...
(Date:5/20/2013)... Posterior fossa subdural hematoma (PFSDH) is a serious and ... But with appropriate treatment, there,s an excellent chance of ... reports a study in the May issue of ... Congress of Neurological Surgeons . The journal is published ... of Wolters Kluwer Health . , The results ...
(Date:5/20/2013)... Hospital emergency departments play a growing role in the ... of hospital admissions and serving increasingly as an advanced ... new RAND Corporation study. , While often targeted as ... rooms remain an important safety net for Americans who ... in slowing the growth of health care costs, according ...
(Date:5/20/2013)... it about toothpaste that transforms the sweet flavor of ... to that mysterious sensory phenomenon in colorful, animated ... Chemical Society,s award-winning Bytesize Science video series ... world,s largest scientific society, explains that the mainstay ingredients ... or SLS for short. When you brush your teeth, ...
(Date:5/20/2013)... As high schoolers prepare for final exams, teens ... -- a prescription stimulant or amphetamine -- to gain ... poll shows only one in 100 parents of teens ... a study drug., Study drugs refer to stimulant medications ... disorder (ADHD); commonly prescribed medicines in this category include ...
Breaking Medicine News(10 mins):Health News:North Shore-LIJ's Feinstein Institute Celebrates Women in Science During National Women’s Health Week 2Health News:North Shore-LIJ's Feinstein Institute Celebrates Women in Science During National Women’s Health Week 3Health News:Study supports 'aggressive' treatment for posterior fossa hematoma in newborns 2Health News:Study supports 'aggressive' treatment for posterior fossa hematoma in newborns 3Health News:Hospital emergency departments gaining in importance, study finds 2Health News:Hospital emergency departments gaining in importance, study finds 3Health News:1 in 10 teens using 'study drugs,' but parents aren't paying attention 2
... Kids treated more than 150 days after an Anterior Cruciate ... including medial meniscal tears, say researchers presenting at the American ... Francisco, CA. "In our research, children who had delayed ... to have an increased chance of also having a medial ...
... FRANCISCO, CA When it comes to treating people ... with the use of magnetic resonance images (MRI), according ... Society for Sports Medicine,s (AOSSM) Specialty Day in San ... sample of volunteers without any hip pain, and discovered ...
... appeared to not affect injury rates and performance in ... Orthopaedic Society for Sports Medicine,s Specialty Day in San ... an injury and enhanced performance in baseball pitchers is ... Carl W. Nissen, MD of Elite Sports Medicine and ...
... (HealthDay News) -- ,There,s little evidence linking disease severity ... in HIV-positive children and teens infected around the time ... experts were concerned that more severe HIV illness -- ... specific highly active antiretroviral therapy regimens might increase the ...
... By Steven Reinberg HealthDay Reporter , FRIDAY, Feb. ... ago that a strange new strain of flu first appeared ... States and eventually much of the globe. The H1N1 ... it proved particularly dangerous to children and younger adults -- ...
... Dentistry at the University of Alberta is hoping its latest ... that target certain types of cancers. , The discovery ... fellow Nicolas Coquelle has shed light on what happens in ... a DNA repair enzyme called polynucleotide kinase/phosphatase, or PNKP. This ...
Cached Medicine News:Health News:Delaying ACL reconstruction in kids may lead to higher rates of associated knee injuries 2Health News:HIV Severity, Treatment Unrelated to Kids' Mental Woes: Study 2Health News:H1N1 'Swine' Flu Makes a Comeback in Mexico 2Health News:New understanding of DNA repair could eventually lead to cancer therapy 2
... is an automated microplate analyzer ... microplate techniques. Open architecture design ... many manufacturers' microplate assays and ... R.I.A. and I.F.A. methods as ...
... MAP D-Type can combine a number ... 180 microplates on a simple to ... instrument is a multifunctional stand-alone device ... larger robotic systems. Custom and standard ...
... provides a fast, accurate assessment of,patient ... patented,state-of-the-art optics yield accurate measurements of ... total hemoglobin. When,used in combination with ... gives a comprehensive and complete assessment ...
The Stat Profile pHOx CO-Oximeter is intended for use in those situations where a more comprehensive profile beyond the measured hematocrit, hemoglobin, and SO2% offered by the Stat Profile pHOx ...
Medicine Products: